NCT01710514View on ClinicalTrials.gov

A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Luteal Hormone Supplementation
Interventions
DRUG

FE 999913 vaginal tablet

Trial Locations (6)

Unknown

Hanabusa Women's Clinic, Kobe

Ebina Ladies Clinic, Ebina

Sophia Ladies Clinic, Sagamihara

Bashamichi Ladies Clinic, Yokohama

IVF Namba Clinic, Osaka

Sanno Hospital, Tokyo

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY